Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen

Exclusion Criteria

• •1. Patients with inadequate IV access
• •2. Patients \<18 years of age
• •3. History or allergy or hypersensitivity to any component of intravenous ibuprofen, aspirin (or aspirin related products) or non-steroidal anti-inflammatory drug (NSAIDs)
• •4. Active hemorrhage or clinically significant bleeding
• •5. Pregnant or nursing
• •6. Patients in the peri-operative period in the setting of coronary artery bypass graft (CABG) surgery
• •7. Inability to understand the requirements of the study, be willing to provide written informed consent (as evidenced by signature on an informed consent document approved by an Institutional Review Board \[IRB\]), and agree to abide by the study restrictions
• •8. Refusal to provide written authorization for use and disclosure of protected health information